We are live on ! Find out more
PA

Parallel Advisors Portfolio holdings

AUM $6.56B
1-Year Est. Return 32.24%
This Fund
S&P 500
This Quarter Est. Return
+8.88%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.4%
10 Year Est. Return
–
AUM
$5B
AUM Growth
+$569M
Cap. Flow
+$92M
Cap. Flow %
1.84%
Top 10 Hldgs %
38.84%
Holding
3,762
New
250
Increased
1,451
Reduced
1,277
Closed
224

Top Buys

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$18.4M
2
ITOT icon
iShares Core S&P Total US Stock Market ETF
ITOT
+$9.77M
3
DYNF icon
BlackRock US Equity Factor Rotation ETF
DYNF
+$5.48M
4
MSFT icon
Microsoft
MSFT
+$4.93M
5
VOO icon
Vanguard S&P 500 ETF
VOO
+$4.9M

Top Sells

Rank Stock Value
1
CORT icon
Corcept Therapeutics
CORT
+$7.34M
2
SBUX icon
Starbucks
SBUX
+$4.7M
3
CMF icon
iShares California Muni Bond ETF
CMF
+$3.3M
4
RSP icon
Invesco S&P 500 Equal Weight ETF
RSP
+$2.63M
5
VB icon
Vanguard Morningstar Small-Cap ETF
VB
+$1.7M

Sector Composition

Rank Sector Weight
1 Technology 17.21%
2 Healthcare 9.68%
3 Financials 7.2%
4 Communication Services 5.16%
5 Consumer Discretionary 4.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FOX icon
2026
Fox Class B
FOX
$23.4B
$27.4K ﹤0.01%
530
+12
+2% +$584
TMDX icon
2027
Transmedics
TMDX
$3B
$27.3K ﹤0.01%
204
-8
-4% -$878
DNB
2028
DELISTED
Dun & Bradstreet
DNB
$27.3K ﹤0.01%
3,003
+2,426
+420% +$21.7K
BCPC
2029
Balchem Corp
BCPC
$5.71B
$27.2K ﹤0.01%
171
+9
+6% +$1.46K
NKTR icon
2030
Nektar Therapeutics
NKTR
$2.55B
$27.2K ﹤0.01%
1,053
-2
-0.2% -$22
BITQ icon
2031
Bitwise Crypto Industry Innovators ETF
BITQ
$379M
$27.2K ﹤0.01%
1,379
– –
RTO icon
2032
Rentokil
RTO
$12.3B
$27.2K ﹤0.01%
1,132
+913
+417% +$21.2K
KXI icon
2033
iShares Global Consumer Staples ETF
KXI
$1.06B
$27.1K ﹤0.01%
415
– –
SM icon
2034
SM Energy
SM
$7.53B
$27.1K ﹤0.01%
1,097
-22
-2% -$533
OPCH icon
2035
Option Care Health
OPCH
$3.66B
$27.1K ﹤0.01%
833
-64
-7% -$2.07K
DGRS icon
2036
WisdomTree Trust WisdomTree US SmallCap Quality Dividend Growth Fund
DGRS
$414M
$27K ﹤0.01%
580
– –
STRL icon
2037
Sterling Infrastructure
STRL
$16.5B
$27K ﹤0.01%
117
+23
+24% +$4.02K
INDY icon
2038
iShares S&P India Nifty 50 Index Fund
INDY
$566M
$27K ﹤0.01%
496
– –
ASND icon
2039
Ascendis Pharma A/S
ASND
$16.9B
$26.9K ﹤0.01%
156
– –
CTBI icon
2040
Community Trust Bancorp
CTBI
$1.41B
$26.8K ﹤0.01%
507
+25
+5% +$1.26K
CVAC
2041
DELISTED
CureVac
CVAC
$26.8K ﹤0.01%
4,940
+472
+11% +$1.87K
AVPT icon
2042
AvePoint
AVPT
$2.76B
$26.8K ﹤0.01%
1,389
-7,887
-85% -$137K
SAIC icon
2043
Saic
SAIC
$5.29B
$26.8K ﹤0.01%
238
-42
-15% -$4.79K
ENVX icon
2044
Enovix
ENVX
$1.03B
$26.7K ﹤0.01%
2,953
-5,684
-66% -$37.1K
RARE icon
2045
Ultragenyx Pharmaceutical
RARE
$2.65B
$26.6K ﹤0.01%
732
+669
+1,062% +$24.1K
UAA icon
2046
Under Armour
UAA
$2.34B
$26.6K ﹤0.01%
3,892
+3,352
+621% +$20.9K
EGP icon
2047
EastGroup Properties
EGP
$10.9B
$26.6K ﹤0.01%
159
-265
-63% -$44.1K
XLG icon
2048
Invesco S&P 500 Top 50 ETF
XLG
$11B
$26.5K ﹤0.01%
508
-281
-36% -$13.4K
PEBO icon
2049
Peoples Bancorp
PEBO
$1.47B
$26.4K ﹤0.01%
864
+492
+132% +$14.4K
IAG icon
2050
IAMGOLD
IAG
$10.5B
$26.3K ﹤0.01%
3,584
+2,623
+273% +$18.4K
80 81
82
83 84

Similar funds

HFS
Hantz Financial Services Southfield, Michigan $6.56B AUM 16.11% 1-Year Est. Return
OCM
Oaktree Capital Management Los Angeles, California $6.56B AUM 42.97% 1-Year Est. Return
LAM
Lyrical Asset Management New York $6.56B AUM 20.06% 1-Year Est. Return
NMIMC
Northwestern Mutual Investment Management Company Milwaukee, Wisconsin $6.6B AUM 19.75% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
TCM
Tenor Capital Management New York $6.49B AUM 3% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return
AG
Algert Global San Francisco, California $6.65B AUM 53.68% 1-Year Est. Return

Parallel Advisors's Q2 2025 Portfolio in Review

As of Q2 2025, Parallel Advisors held 3,762 positions worth $5B, up 13% from $4.43B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Parallel Advisors's Q2 2025 filing shows 250 new, 1,451 increased, 1,277 reduced and 224 closed positions. Its largest new stake was Vanguard 0-3 Month Treasury Bill ETF: 32,722 shares worth $2.47M. The largest sale was Corcept Therapeutics, an estimated $7.34M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.

  • Parallel Advisors's largest Q2 2025 buy was Vanguard 0-3 Month Treasury Bill ETF: 32,722 shares worth $2.47M.
  • Parallel Advisors added most to iShares Core S&P 500 ETF in Q2 2025, an estimated $18.4M increase.
  • Parallel Advisors's biggest Q2 2025 reduction was Corcept Therapeutics, cutting an estimated $7.34M.
  • Parallel Advisors fully exited Discover Financial Services in Q2 2025, selling an estimated $1.22M.
  • Parallel Advisors's ten largest holdings make up 39% of its $5B portfolio in Q2 2025.
  • Parallel Advisors opened 250 new positions and closed 224 in Q2 2025.
  • Parallel Advisors's portfolio value rose 13% quarter-over-quarter to $5B.

Based on Parallel Advisors's 13F filing for Q2 2025, filed 8 Jul 2025.